Y Intercept Hong Kong Ltd Purchases 5,477 Shares of HCA Healthcare, Inc. $HCA

Posted by George Bondi on Jul 5th, 2026

Y Intercept Hong Kong Ltd lifted its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 66.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,667 shares of the company’s stock after purchasing an additional 5,477 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in HCA Healthcare were worth $6,468,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare during the 3rd quarter worth about $26,000. Holos Integrated Wealth LLC acquired a new position in HCA Healthcare in the fourth quarter worth about $29,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at approximately $31,000. JPL Wealth Management LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at $34,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.1%

HCA Healthcare stock opened at $409.99 on Friday. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The company’s 50-day moving average is $400.65 and its two-hundred day moving average is $462.43. The company has a market cap of $90.95 billion, a PE ratio of 14.10, a PEG ratio of 1.30 and a beta of 1.12.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the prior year, the company earned $6.45 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Wall Street Analyst Weigh In

HCA has been the topic of several recent analyst reports. Barclays reduced their target price on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Jefferies Financial Group reaffirmed a “buy” rating and set a $525.00 price objective on shares of HCA Healthcare in a research note on Friday, April 24th. Oppenheimer cut their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Sanford C. Bernstein decreased their price target on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a research report on Thursday, June 4th. Finally, Stephens reduced their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $503.00.

Get Our Latest Analysis on HCA Healthcare

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.